Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Eur Neuropsychopharmacol ; 33: 126-138, 2020 04.
Article in English | MEDLINE | ID: mdl-32057593

ABSTRACT

The adolescent brain displays high vulnerability to the deleterious effects of ethanol, including greater risk of developing alcohol use disorder later in life. Here, we characterized the gene expression of the endocannabinoid system (ECS) and relevant signaling systems associated with neuroinflammation and emotional behaviors in the brain of young adult control and ethanol-exposed (EtOH) rats. We measured mRNA levels of candidate genes using quantitative real time PCR in the medial prefrontal cortex (mPFC), amygdala and hippocampus. EtOH rats were generated by maintenance on an intermittent and voluntary ethanol consumption during adolescence using the two-bottle choice paradigm (4 days/week for 4 weeks) followed by 2 week-withdrawal, a time-point of withdrawal with no physical symptoms. Mean differences and effect sizes were calculated using t-test and Cohen's d values. In the mPFC and hippocampus, EtOH rats had significantly higher mRNA expression of endocannabinoid-signaling (mPFC: Ppara, Dagla, Daglb and Napepld; and hippocampus: Cnr2, Dagla and Mgll) and neuroinflammation-associated genes (mPFC: Gfap; and hippocampus: Aif1) than in controls. Moreover, EtOH rats had significantly higher mRNA expression of neuropeptide Y receptor genes (Npy1r, Npy2r and Npy5r) in the hippocampus. Finally, EtOH rats also displayed higher plasma endocannabinoid levels than controls. In conclusion, these results suggest that adolescent ethanol exposure can lead to long-term alterations in the gene expression of the ECS and other signaling systems involved in neuroinflammation and regulation of emotional behaviors in key brain areas for the development of addiction.


Subject(s)
Alcohol Drinking/adverse effects , Central Nervous System Depressants/adverse effects , Endocannabinoids/genetics , Endocannabinoids/metabolism , Ethanol/adverse effects , Inflammation Mediators/metabolism , Animals , Anxiety/psychology , Emotions , Gene Expression/drug effects , Male , Memory/drug effects , Motor Activity/drug effects , Psychology, Adolescent , Psychomotor Performance/drug effects , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Rats , Rats, Wistar , Receptors, Neuropeptide Y/drug effects , Receptors, Neuropeptide Y/genetics , Receptors, Neuropeptide Y/metabolism
2.
Curr Neuropharmacol ; 17(11): 1056-1070, 2019.
Article in English | MEDLINE | ID: mdl-31204624

ABSTRACT

BACKGROUND: Cognitive reserve (CR) refers to the ability of an individual to cope with brain pathology remaining free of cognitive symptoms. This protective factor has been related to compensatory and more efficient brain mechanisms involved in resisting brain damage. For its part, Brain reserve (BR) refers to individual differences in the structural properties of the brain which could also make us more resilient to suffer from neurodegenerative and mental diseases. OBJECTIVE: This review summarizes how this construct, mainly mediated by educational level, occupational attainment, physical and mental activity, as well as successful social relationships, has gained scientific attention in the last years with regard to diseases, such as neurodegenerative diseases, stroke or traumatic brain injury. Nevertheless, although CR has been studied in a large number of disorders, few researches have addressed the role of this concept in drug addiction. METHODS: We provide a selective overview of recent literature about the role of CR and BR in preventing substance use onset. Likewise, we will also discuss how variables involved in CR (healthy leisure, social support or job-related activities, among others) could be trained and included as complementary activities of substance use disorder treatments. RESULTS: Evidence about this topic suggests a preventive role of CR and BR on drug use onset and when drug addiction is established, these factors led to less severe addiction-related problems, as well as better treatment outcomes. CONCLUSION: CR and BR are variables not taken yet into account in drug addiction. However, they could give us a valuable information about people at risk, as well as patient's prognosis.


Subject(s)
Cognitive Reserve , Substance-Related Disorders , Humans
3.
Transl Psychiatry ; 7(4): e1077, 2017 04 04.
Article in English | MEDLINE | ID: mdl-28375206

ABSTRACT

Anxious depression is a prevalent disease with devastating consequences and a poor prognosis. Nevertheless, the neurobiological mechanisms underlying this mood disorder remain poorly characterized. The LPA1 receptor is one of the six characterized G protein-coupled receptors (LPA1-6) through which lysophosphatidic acid acts as an intracellular signalling molecule. The loss of this receptor induces anxiety and several behavioural and neurobiological changes that have been strongly associated with depression. In this study, we sought to investigate the involvement of the LPA1 receptor in mood. We first examined hedonic and despair-like behaviours in wild-type and maLPA1 receptor null mice. Owing to the behavioural response exhibited by the maLPA1-null mice, the panic-like reaction was assessed. In addition, c-Fos expression was evaluated as a measure of the functional activity, followed by interregional correlation matrices to establish the brain map of functional activation. maLPA1-null mice exhibited anhedonia, agitation and increased stress reactivity, behaviours that are strongly associated with the psychopathological endophenotype of depression with anxiety features. Furthermore, the functional brain maps differed between the genotypes. The maLPA1-null mice showed increased limbic-system activation, similar to that observed in depressive patients. Antidepressant treatment induced behavioural improvements and functional brain normalisation. Finally, based on validity criteria, maLPA1-null mice are proposed as an animal model of anxious depression. Here, for we believe the first time, we have identified a possible relationship between the LPA1 receptor and anxious depression, shedding light on the unknown neurobiological basis of this subtype of depression and providing an opportunity to explore new therapeutic targets for the treatment of mood disorders, especially for the anxious subtype of depression.


Subject(s)
Anxiety/physiopathology , Depression/metabolism , Endophenotypes , Mice, Knockout/psychology , Receptors, Lysophosphatidic Acid/deficiency , Anhedonia/physiology , Animals , Anxiety/metabolism , Brain/metabolism , Genes, fos/genetics , Limbic System/metabolism , Lysophospholipids/metabolism , Male , Mice , Models, Animal , Receptors, Lysophosphatidic Acid/drug effects , Receptors, Lysophosphatidic Acid/metabolism , Stress, Psychological
4.
Neuroscience ; 330: 17-25, 2016 08 25.
Article in English | MEDLINE | ID: mdl-27235742

ABSTRACT

The use of more ethological animal models to study the neurobiology of anxiety has increased in recent years. We assessed the effect of an environmental enrichment (EE) protocol (24h/day over a period of two months) on anxiety-related behaviors when aged Wistar rats (21months old) were confronted with cat odor stimuli. Owing to the relationship between GABAergic interneurons and the anxiety-related neuronal network, we examined changes in the expression of Parvalbumin (PV) and 67kDa form of glutamic acid decarboxylase (GAD-67) immunoreactive cells in different brain regions involved in stress response. Behavioral results revealed that enriched rats traveled further and made more grooming behaviors during the habituation session. In the cat odor session, they traveled longer distances and they showed more active interaction with the odor stimuli and less time in freezing behavior. Zone analysis revealed that the enriched group spent more time in the intermediate zone according to the proximity of the predator odor. Regarding the neurobiological data, the EE increased the expression of PV-positive cells in some medial prefrontal regions (cingulate (Cg) and prelimbic (PL) cortices), whereas the GAD-67 expression in the basolateral amygdala was reduced in the enriched group. Our results suggest that EE is able to reduce anxiety-like behaviors in aged animals even when ethologically relevant stimuli are used. Moreover, GABAergic interneurons could be involved in mediating this resilient behavior.


Subject(s)
Aging/psychology , Anxiety/therapy , Environment , GABAergic Neurons/physiology , Interneurons/physiology , Aging/pathology , Aging/physiology , Animals , Anxiety/pathology , Anxiety/physiopathology , Cats , Exploratory Behavior/physiology , GABAergic Neurons/pathology , Glutamate Decarboxylase/metabolism , Grooming/physiology , Housing, Animal , Immunohistochemistry , Interneurons/pathology , Models, Animal , Odorants , Parvalbumins/metabolism , Physical Stimulation , Predatory Behavior , Rats, Wistar , Resilience, Psychological
5.
Brain Struct Funct ; 219(5): 1659-72, 2014 Sep.
Article in English | MEDLINE | ID: mdl-23775489

ABSTRACT

LPA1 receptor is one of the six characterized G protein-coupled receptors (LPA1-6) through which lysophosphatidic acid acts as an intercellular signaling molecule. It has been proposed that this receptor has a role in controlling anxiety-like behaviors and in the detrimental consequences of stress. Here, we sought to establish the involvement of the LPA1 receptor in emotional regulation. To this end, we examined fear extinction in LPA1-null mice, wild-type and LPA1 antagonist-treated animals. In LPA1-null mice we also characterized the morphology and GABAergic properties of the amygdala and the medial prefrontal cortex. Furthermore, the expression of c-Fos protein in the amygdala and the medial prefrontal cortex, and the corticosterone response following acute stress were examined in both genotypes. Our data indicated that the absence of the LPA1 receptor significantly inhibited fear extinction. Treatment of wild-type mice with the LPA1 antagonist Ki16425 mimicked the behavioral phenotype of LPA1-null mice, revealing that the LPA1 receptor was involved in extinction. Immunohistochemistry studies revealed a reduction in the number of neurons, GABA+ cells, calcium-binding proteins and the volume of the amygdala in LPA1-null mice. Following acute stress, LPA1-null mice showed increased corticosterone and c-Fos expression in the amygdala. In conclusion, LPA1 receptor is involved in emotional behaviors and in the anatomical integrity of the corticolimbic circuit, the deregulation of which may be a susceptibility factor for anxiety disorders and a potential therapeutic target for the treatment of these diseases.


Subject(s)
Emotions/physiology , Extinction, Psychological/physiology , Fear , Receptors, Lysophosphatidic Acid/metabolism , Stress, Psychological/metabolism , Amygdala/cytology , Animals , Conditioning, Classical , Corticosterone/metabolism , Corticosterone/pharmacology , Cues , Disease Models, Animal , Emotions/drug effects , Extinction, Psychological/drug effects , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Isoxazoles/pharmacology , Lysophospholipids/pharmacology , Male , Mice , Mice, Knockout , Neurons/drug effects , Neurons/physiology , Phosphopyruvate Hydratase/metabolism , Propionates/pharmacology , Receptors, Lysophosphatidic Acid/genetics , Time Factors
6.
Genes Brain Behav ; 8(8): 772-84, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19689455

ABSTRACT

Lysophosphatidic acid (LPA) has emerged as a new regulatory molecule in the brain. Recently, some studies have shown a role for this molecule and its LPA(1) receptor in the regulation of plasticity and neurogenesis in the adult brain. However, no systematic studies have been conducted to investigate whether the LPA(1) receptor is involved in behavior. In this study, we studied the phenotype of maLPA(1)-null mice, which bear a targeted deletion at the lpa(1) locus, in a battery of tests examining neurologic performance, habituation in exploratory behavior in response to low and mild anxiety environments and spatial memory. MaLPA(1)-null mutants showed deficits in both olfaction and somesthesis, but not in retinal or auditory functions. Sensorimotor co-ordination was impaired only in the equilibrium and grasping reflexes. The mice also showed impairments in neuromuscular strength and analgesic response. No additional differences were observed in the rest of the tests used to study sensoriomotor orientation, limb reflexes and co-ordinated limb use. At behavioral level, maLPA(1)-null mice showed an impaired exploration in the open field and increased anxiety-like response when exposed to the elevated plus maze. Furthermore, the mice exhibit impaired spatial memory retention and reduced use of spatial strategies in the Morris water maze. We propose that the LPA(1) receptor may play a major role in both spatial memory and response to anxiety-like conditions.


Subject(s)
Anxiety/genetics , Brain Chemistry/genetics , Lysophospholipids/metabolism , Receptors, Lysophosphatidic Acid/genetics , Animals , Anxiety/metabolism , Anxiety/physiopathology , Behavior, Animal/physiology , Cerebellar Diseases/genetics , Cerebellar Diseases/metabolism , Cerebellar Diseases/physiopathology , Exploratory Behavior/physiology , Maze Learning/physiology , Memory Disorders/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Muscle Strength/genetics , Neuropsychological Tests , Phenotype
SELECTION OF CITATIONS
SEARCH DETAIL
...